Inventor

COHEN SASSON

IL15 patents

⚠️ This page may combine multiple inventors who share the name “COHEN SASSON”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

TEVA PHARMA

8 patents

US6528685B2Mar 4, 2003

Compositions containing and methods of using 1-aminoindan and derivatives thereof and process for preparing optically active 1-aminoindan derivatives

TEVA PHARMA47 citations96

US6277886B1Aug 21, 2001

Pharmaceutical compositions comprising S-(−)-N-propargyl-1-aminoindan

TEVA PHARMA66 citations96

US5914349AJun 22, 1999

Compositions containing and methods of using 1-aminoindan and derivatives thereof and process for preparing optically active 1-aminoindan derivatives

TEVA PHARMA50 citations96

US5877221AMar 2, 1999

Compositions containing and methods of using 1-aminoindan and derivatives thereof and process for preparing optically active 1-aminoindan derivatives

TEVA PHARMA52 citations96

US5994408ANov 30, 1999

Compositions containing and methods of using 1-aminoindan and derivatives thereof and process for preparing optically active 1-aminoindan derivatives

TEVA PHARMA54 citations95

US5840756ANov 24, 1998

Pharmaceutical composition of L-DOPA ester

TEVA PHARMA98 citations92

US5565462AOct 15, 1996

Composition for topical treatment of psoriasis and atopic dermatitis comprising a xanthine derivative

TEVA PHARMA64 citations90

US6737547B1May 18, 2004

Compositions containing and methods of using N-acyl-1H-aminoindenes

TEVA PHARMA9 citations69

PURDUE FREDERICK CO

5 patents

US4104397AAug 1, 1978

1,8-Ethano-5-oxo-octa- and -decahydroquinolines and mydriatic compositions thereof

PURDUE FREDERICK CO1 citations62

US4309544AJan 5, 1982

Preparation of 6-oxa-1-azatricyclo(6.2.2.02,7)dodecane-5-ones

PURDUE FREDERICK CO0 citations52

ISRAEL STATE

1 patent

US4112082ASep 5, 1978

Pharmaceutical composition for treating glaucoma and compound 1,3,2-dioxaphospheringnes

ISRAEL STATE5 citations53

OPPENHEIMER EDNA

1 patent

US4146628AMar 27, 1979

Antiarrhythmic quinuclidine carboxylic acid xylidide and method of producing the same and similar compounds

OPPENHEIMER EDNA2 citations44

COHEN SASSON

TEVA PHARMA

Compositions containing and methods of using 1-aminoindan and derivatives thereof and process for preparing optically active 1-aminoindan derivatives

Pharmaceutical compositions comprising S-(−)-N-propargyl-1-aminoindan

Compositions containing and methods of using 1-aminoindan and derivatives thereof and process for preparing optically active 1-aminoindan derivatives

Compositions containing and methods of using 1-aminoindan and derivatives thereof and process for preparing optically active 1-aminoindan derivatives

Compositions containing and methods of using 1-aminoindan and derivatives thereof and process for preparing optically active 1-aminoindan derivatives

Pharmaceutical composition of L-DOPA ester

Composition for topical treatment of psoriasis and atopic dermatitis comprising a xanthine derivative

Compositions containing and methods of using N-acyl-1H-aminoindenes

PURDUE FREDERICK CO

Spiro (1,3-dioxolane-4,3&#39;) quinuclidine compounds

6-Oxa-1-aza tricyclo dodecan-5-ones as psychomotor stimulators

Novel heterocyclic compounds and pharmaceutical composition containing them

1,8-Ethano-5-oxo-octa- and -decahydroquinolines and mydriatic compositions thereof

Preparation of 6-oxa-1-azatricyclo(6.2.2.02,7)dodecane-5-ones

ISRAEL STATE

Pharmaceutical composition for treating glaucoma and compound 1,3,2-dioxaphospheringnes

OPPENHEIMER EDNA

Antiarrhythmic quinuclidine carboxylic acid xylidide and method of producing the same and similar compounds

Spiro (1,3-dioxolane-4,3') quinuclidine compounds